A legal battle over a former president’s executive order on mail-in voting is back in court, raising fresh questions about election policies ahead of key voting periods. Meanwhile, a major tech company has reached a settlement imposing new restrictions on its operations, marking a significant shift in regulatory oversight. The FDA has given the green light to a groundbreaking treatment for pancreatic cancer, offering new hope for patients facing the aggressive disease. As the fifth anniversary of a deadly bombing at a historic site approaches, officials and survivors reflect on the enduring impact of the attack. Separately, the newly appointed Federal Reserve Chair will address financial markets for the first time, with economists closely watching for clues on economic policy direction.
In today's issue: ▪ Trump’s mail-in voting order challenged again ▪ Meta agrees to restrictions in settlement ▪ FDA approves major pancreatic cancer treatment ▪ Abbey Gate bombing fifth anniversary Federal Reserve Chair Kevin Warsh will step into the spotlight this week as he delivers his first major speech as chair, with investors anxious to see whether he...
